• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PACEMAKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PACEMAKER Back to Search Results
Model Number W173
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Inappropriate or Unexpected Reset (2959)
Patient Problem Malaise (2359)
Event Date 08/01/2023
Event Type  Injury  
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event Description
It was reported that the patient implanted with this cardiac resynchronization therapy pacemaker (crt-p) was feeling unwell since august.Upon further evaluation, it was determined that the crt-p had entered safety mode.The patient was admitted to the hospital and scheduled for device replacement.This crt-p remains in service at this time.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that the patient implanted with this cardiac resynchronization therapy pacemaker (crt-p) was feeling unwell since august.Upon further evaluation, it was determined that the crt-p had entered safety mode.The patient was admitted to the hospital and scheduled for device replacement.This crt-p remains in service at this time.No additional adverse patient effects were reported.Additional information received reported that this cardiac resynchronization therapy pacemaker (crt-p) was explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode and that bradycardia therapy remained available.The system resets caused the device to enter safety mode.Engineers determined that this device was demonstrating behavior consistent with a high internal cell impedance within the battery.The high internal impedance resulted in the system resets due to temporary high-power consumption and subsequent reversion to safety mode operation.Boston scientific has issued a field safety notice regarding ingenio extended life (el) and cardiac resynchronization therapy pacemaker (crt-p) devices that may exhibit this behavior.This particular device is included in the high impedance in ingenio extended life (el) pacemaker and crt-p advisory population.
 
Event Description
It was reported that the patient implanted with this cardiac resynchronization therapy pacemaker (crt-p) was feeling unwell since august.Upon further evaluation, it was determined that the crt-p had entered safety mode.The patient was admitted to the hospital and scheduled for device replacement.This crt-p remains in service at this time.No additional adverse patient effects were reported.Additional information received reported that this cardiac resynchronization therapy pacemaker (crt-p) was explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
IMPLANTABLE PACEMAKER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18089340
MDR Text Key327586825
Report Number2124215-2023-62690
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 04/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/12/2015
Device Model NumberW173
Device Catalogue NumberW173
Device Lot Number114161
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/31/2023
Initial Date FDA Received11/07/2023
Supplement Dates Manufacturer Received11/21/2023
03/26/2024
Supplement Dates FDA Received12/12/2023
04/05/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/15/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-